Takis qualified as a semifinalist at the European Health Catapult organized by EIT Health with the support of the Health Axis Europe. This makes  us among the 14 best biotech companies in Europe!

EIT Health is a network of the best-in-class health innovators backed by the EU, aimed at ensuring a longer and healthier life for European citizens.

European Health Catapult is a training and competition programme that awards the best business concepts from medtech, biotech and digital health across Europe.

Dr Fabio Palombo, Head of Personalized Cancer Vaccine program, will attend the semi-finals in Delft from 24-26 September 2019, where we will participate in Training and Selection Days. This is a great opportunity for us to get high quality training in business plan modeling, deal negotiation and pitch as well as to extend our network and approach top level investors.

We are really looking forward to this amazing experience. We are ready to do our best to enhance Italian research in Europe.  

Read about: https://www.europeanhealthcatapult.eu/about/